Home > Insider Trading > Filing (0000929638-23-000895)

Filing Details

Accession Number:: 0000929638-23-000895
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-22 17:07:44
Reporting Period:: 2023-03-20

Accepted Time:: 2023-03-22 17:07:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1821586	Moonlake Immunotherapeutics	MLTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1599214	Bihua Chen	C/O Cormorant Asset Management, Lp 200 Clarendon Street, 52Nd Floor Boston MA 02116		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Acquisiton	2023-03-20	446,881	$19.36	3,296,881	No	4	P	Indirect	See Footnotes
Class A Ordinary Shares	Acquisiton	2023-03-20	63,700	$20.42	3,360,581	No	4	P	Indirect	See Footnotes
Class A Ordinary Shares	Acquisiton	2023-03-20	78,008	$21.08	3,438,589	No	4	P	Indirect	See Footnotes
Class A Ordinary Shares	Acquisiton	2023-03-21	238,511	$21.70	3,677,100	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Ordinary Shares	3,215,000	Indirect	See Footnotes

Footnotes

Helix Holdings LLC is the record holder of these securities. Bihua Chen is the manager of Helix Holdings LLC and has voting and investment discretion with respect to the securities held of record by Helix Holdings LLC. Ms. Chen disclaims any beneficial ownership of the securities held by Helix Holdings LLC other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $18.81 to $19.80 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
Various funds (the "Cormorant Funds") managed by Cormorant Asset Management, LP are the record holders of these securities. Bihua Chen is the founder and managing member of Cormorant Asset Management, LP and has voting and investment discretion with respect to the ordinary shares held by the Cormorant Funds. Ms. Chen disclaims any beneficial ownership of such securities other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $19.81 to $20.80 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $20.81 to $21.25 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.
Represents ordinary shares purchased in a series of open market transactions on the transaction date at prices ranging from $21.09 to $22.00 per ordinary share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ordinary shares purchased at each price.